Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COMPARE: Prasugrel vs. Ticagrelor in STEMI
NCT03435133Completed
- Sponsor
- Aortica
- Start
- Nov 2015
- Primary completion
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of ticagrelor in ST elevation myocardial infarction (STEMI) (2 arms), sponsored by Aortica. Primary endpoint: Infarct size at 6 months. Started Nov 2015; status: completed.
02
Drugs
ticagrelor
03
Conditions
ST elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT03435133.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03435133.